posted on 2024-12-16, 16:28authored byMackenzie
K. Wyllie, Clare K. Morris, Nicholas H. Moeller, Henry A. M. Schares, Ramkumar Moorthy, Christopher A. Belica, Michael J. Grillo, Özlem Demir, Alex M. Ayoub, Michael A. Carpenter, Hideki Aihara, Reuben S. Harris, Rommie E. Amaro, Daniel A. Harki
The APOBEC3 family of polynucleotide
cytidine deaminases
has diverse
roles as viral restriction factors and oncogenic mutators. These enzymes
convert cytidine to uridine in single-stranded (ss)DNA, inducing genomic
mutations that promote drug resistance and tumor heterogeneity. Of
the seven human APOBEC3 members, APOBEC3A (A3A) and APOBEC3B (A3B)
are most implicated in driving pro-tumorigenic mutations. How these
enzymes engage and selectively deaminate ssDNA over RNA is not well
understood. We previously conducted molecular dynamics (MD) simulations
that support the role of sugar conformation as a key molecular determinant
in nucleic acid recognition by A3B. We hypothesize that A3A and A3B
selectively deaminate substrates in the 2′-<i>endo</i> (DNA) conformation and show reduced activity for 3′-<i>endo</i> (RNA) conformation substrates. Consequently, we have
characterized A3A- and A3B-binding and deaminase activity with chimeric
oligonucleotides containing cytidine analogues that promote either
the 2′-<i>endo</i> or 3′-<i>endo</i> conformation. Using fluorescence polarization and gel-based deamination
assays, we determined that sugar conformation preferentially impacts
the ability of these enzymes to deaminate substrates and less so binding
to substrates. Using MD simulations, we identify specific active site
interactions that promote selectivity based on the 2′-<i>endo</i> conformation. These findings help inform the biological
functions of A3A and A3B in providing antiviral innate immunity and
pathogenic functions in cancer.